Association of homocysteinemia with high concentrations of serum insulin and uric acid in Brazilian subjects with metabolic syndrome genotyped for C677T polymorphism in the methylenetetrahydrofolate reductase gene

Nutrition Research

Volumn 28, Issue 11, 2008, Pages 760-766

  Uehara, Sofia Kimi ^a   Rosa, Glorimar ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

C677T polymorphism in the MTHFR gene; Cardiovascular disease; Human; Hyperhomocysteinemia; Insulin resistance; Metabolic syndrome

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); COBALAMIN; FOLIC ACID; HOMOCYSTEINE; INSULIN; PYRIDOXINE; URIC ACID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; HOMOCYSTINURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; SMOKING;

ADULT; BODY MASS INDEX; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; FOLIC ACID DEFICIENCY; GENOTYPE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; INSULIN; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; URIC ACID; VITAMIN B 12 DEFICIENCY;

EID: 55449092833     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2008.09.006     Document Type: Article

References (50)

1. Reaven G.M. Banting lecture: role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1606
2. Meigs J.B., Jacques P.F., Selhub J., Singer D.E., Nathan D.M., Rifai N., et al. Fasting plasma homocysteine levels in the insulin resistance syndrome-The Framingham Offspring Study. Diabetes Care 24 (2001) 1403-1410
3. Selhub J. Homocysteine metabolism. Annu Rev Nutr 19 (1999) 217-246
4. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
5. Jacques P.F., Bostom A.G., Wilson P.W.F., Rich S., Rosenberg I.H., and Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 73 (2001) 613-621
6. Godsland I.F., Rosankiewicz J.R., Proudler A.J., and Johnston D.G. Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. J Clin Endocrinol Metab 86 (2001) 719-723
7. Björck J., Hellgren M., Rastam L., and Lindblad U. Associations between serum insulin and homocysteine in a Swedish population-a potential link between the metabolic syndrome and hyperhomocysteinemia: the Skarabog Project. Metabolism 55 (2006) 1007-1013
8. Rhee E.J., Hwang S.T., Lee W.Y., Yoon J.H., Kim B.J., Kim B.S., et al. Relationship between metabolic syndrome categorized by newly recommended by International Diabetes Federation criteria with plasma homocysteine concentration. Endocr J 54 6 (2007) 995-1002
9. Giltay E.J., Hoogeveen E.K., Elbers J.M.H., Gooren L.J.G., Asscheman H., and Stehouwer C.D.A. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. Atherosclerosis 139 (1998) 197-198
10. Abbasi F., Facchini F., Humphreys M.H., and Reaven G.M. Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal. Atherosclerosis 146 (1999) 175-178
11. Emoto M., Kanda H., Shoji T., Kawagishi T., Komatsu M., Mori K., et al. Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care 24 2 (2001) 533-538
12. Dicker-Brown A., Fonseca V.A., Fink L.M., and Kern P.A. The effect of glucose and insulin on the activity of methylene tetrahydrofolate reductase and cystathionine-β-synthase: studies in hepatocytes. Atherosclerosis 158 (2001) 297-301
13. Sánchez-Margalet V., Valle M., Ruz F.J., Gascón F., Mateo J., and Goberna R. Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects. J Nutr Biochem 13 (2002) 75-79
14. Oron-herman M., Rosenthal T., and Sela B.A. Hyperhomocysteinemia as a component of syndrome X. Metabolism 52 (2003) 1491-1495
15. 12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol 151 (2004) 483-489
16. Golbahar J., Aminzadeh M.A., Kassab S.E., and Omrani G.R. Hyperhomocysteinemia induces insulin resistance in male Sprague-Dawley rats. Diabetes Res Clin Pract 76 (2007) 1-5
17. Castro L.C.V., Franceschini S.C.C., Priore S.E., and Pelúzio M.C.G. Nutrição e doenças cardiovasculares: os marcadores de risco em adultos. Rev Nutr 17 3 (2004) 369-377
18. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 285 (2001) 2486-2497
19. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 277 (1997) 925
20. Food Processor Nutrition Analysis System. Version 12.0 (1984), ESHA Corporation, USA
21. Gibson R.S. Principles of nutritional assessment (1990), Oxford University Press, New York
22. WHO. Obesity: prevention and managing the global epidemic: report of a WHO consultation on obesity (1998) Geneva
23. Lohman T.G., Roche A.F., and Martorell R. Anthropometric standardization reference manual (1988), Human Kinetics, Illinois
24. Durmin J.V., and Womersly J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32 (1974) 77-94
25. Heyward V.H., and Stolarczyk L.M. Avaliação da composição corporal aplicada (2000), Manole, São Paulo
26. Mion Jr. D., Machado C.A., Gomes M.A.M., Nobre F., Kohlmann Jr. O., Amodeo C., et al. IV Diretrizes Brasileiras de Hipertensão Arterial. Arq Bras Cardiol 82 Suppl 4 (2004) 1-14
27. Friedwald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
28. Matthews D.R., Hosker J.P., Rudenski B.A., Naylor D.F., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
29. Ubbink J.B., Hayward-Vermaak W.J., and Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 365 (1991) 441-446
30. Walsh P.S., Metzger D.A., and Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 10 (1991) 506-513
31. Mutchinick O.M., López M.A., Luna L., Waxman J., Babinsky V.E., and Ryvemce Collaborative Group. High prevalence of the thermolabile methylenetetrahydrofolate reductase variant in Mexico: a country with a very high prevalence of neural tube defects. Mol Genet Metab 68 (1999) 461-467
32. Pagano M., and Gauvreau K. Princípios de Bioestatística (2004), Ed. Thomson Pioneira, São Paulo, SP
33. Emery A.E.H. Hardy-Weinberg equilibrium and the estimation of gene frequencies. In: Emery A.E.H. (Ed). Methodology in Medical Genetics: An Introduction to Statistical Methods (1976), Churchill Livingstone, Edinburgh 3-9
34. Statistical Package for the Social Sciences (SPSS) 11.0 for Windows (2001), SPSS Inc., Chicago
35. 12, pantothenic acid, biotin, and choline (2000), National Academy Press, Washington, DC
36. IBGE - Instituto Brasileiro de Geografia e Estatística. Pesquisa de Orçamentos Familiares (POF) - Análise de disponibilidade domiciliar de alimentos e do estado nutricional no Brasil (2004), IBGE, Rio de Janeiro
37. Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Regist 61 (1996) 8781-8797
38. Agência Nacional de Vigilância Sanitária. RDC n. 344, de 13 de dezembro de 2002. Aprova o regulamento técnico para a fortificação das farinhas de trigo e das farinhas de milho com ferro e ácido fólico. [cited 2007 September 8]. Available from:. http://www.anvisa.gov.br/legis/resol/2002/344_02rdc.htm
39. Geloneze B., Geloneze S.R., Ermetice M.N., Repetto E.M., and Tambascia M.A. The threshold value for insulin resistance (HOMA-IR) in an admixtured population. IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract 24 (2006) 219-220
40. 12, pantothenic acid, biotin, and choline (1998), National Academy Press, Washington, DC
41. Omenn G.S., Beresford S.A.A., and Motulsky A.G. Preventing coronary heart disease-B vitamins and homocysteine. Circulation 97 (1998) 421-424
42. Guven A., Inanc F., Kilinc M., and Ekerbicer H. Plasma homocysteine and lipoprotein (a) levels in Turkish patients with Metabolic Syndrome. Heart Vessels 20 (2005) 290-295
43. Hayden M.R., and Tyagi S. Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr Metab 1 (2004) 1-15
44. Najib S., and Sanchez-Margalet V. Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect. J Mol Endocrinol 27 (2001) 85-91
45. Patterson S., Flatt P.R., Brennan L., Newsholme P., and McClenaghan N.H. Detrimental actions of metabolic syndrome risk factor, homocysteine, on pancreatic β-cell glucose metabolism and insulin secretion. J Endocrinol 189 (2006) 301-310
46. Welch G.N., and Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 338 (1998) 1042-1050
47. Russo G.T., Di Benedetto A., Alessi E., Ientile R., Antico A., Nicocia G., et al. Mild hyperhomocysteinemia and the common C677T polymorphism of methylene tetrahydrofolate reductase gene are not associated with metabolic syndrome in type 2 diabetes. J Endocrinol Invest 29 3 (2006) 201-207
48. 12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost 83 (2000) 563-570
49. Pullin C.H., Ashfielg-Watt P.A.L., Burr M.L., Clark Z.E., Lewis M.J., Moat S.J., et al. Optimization of dietary folate or low-dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults, irrespective of the methylenetetrahydrofolate reductase (C677T) genotype. J Am Coll Cardiol 38 (2001) 1799-1805
50. Lucock M., and Yates Z. Synergy between 677 TT MTHFR genotype and related folate SNPs regulates homocysteine levels. Nutr Res 26 (2006) 180-185